false0001456189--12-31Q1 0001456189 2026-01-01 2026-03-31 0001456189 2026-03-31 0001456189 2025-01-01 2025-03-31 0001456189 2025-12-31 0001456189leat:ShareRepurchasePlanMember 2025-08-12 0001456189leat:ShareRepurchasePlanMember 2025-08-01 2025-08-12 0001456189leat:ShareRepurchasePlanMember 2026-01-01 2026-03-31 0001456189leat:ShareRepurchasePlanMember 2026-03-31 0001456189leat:ShareRepurchasePlanMember 2025-01-01 2025-12-31 0001456189leat:ShareRepurchasePlanMember 2025-12-31 0001456189 2026-05-08 0001456189us-gaap:LineOfCreditMember 2026-03-31 0001456189us-gaap:LineOfCreditMember 2026-01-01 2026-03-31 0001456189leat:SalesOfLeattbraceProductsMember 2026-01-01 2026-03-31 0001456189leat:SalesOfLeattbraceProductsMember 2025-01-01 2025-03-31 0001456189leat:SalesOfLeattbraceProductsMember 2025-12-31 0001456189leat:InnovationMember 2024-01-01 2024-06-30 0001456189leat:InnovationMember 2026-01-01 2026-03-31 0001456189leat:InnovationMember 2025-01-01 2025-03-31 0001456189leat:InnovationMember 2024-07-01 2025-06-30 0001456189leat:SalesOfLeattbraceProductsMember 2026-03-31 0001456189leat:InnovationMember 2025-07-01 2026-06-30 0001456189 2025-01-01 2025-12-31 0001456189us-gaap:NotesPayableToBanksMember 2022-12-01 0001456189us-gaap:NotesPayableToBanksMember 2022-12-01 2022-12-01 0001456189us-gaap:SubsequentEventMember 2026-04-01 2026-04-30 0001456189leat:USShortTermLoanMember 2026-03-31 0001456189leat:SouthAfricanShortTermLoanMember 2026-01-01 2026-03-31 0001456189leat:SouthAfricanShortTermLoanMember 2026-03-31 0001456189leat:USShortTermLoanMember 2026-01-01 2026-03-31 0001456189leat:ConsumerAndAthleteDirectRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001456189leat:ConsumerAndAthleteDirectRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001456189leat:DealerDirectRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001456189leat:DealerDirectRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001456189leat:InternationalDistributorRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001456189leat:InternationalDistributorRevenuesMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001456189us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001456189us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001456189 2024-12-31 0001456189 2025-03-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001456189us-gaap:RetainedEarningsMember 2025-12-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001456189us-gaap:CommonStockMember 2025-12-31 0001456189us-gaap:PreferredStockMember 2025-12-31 0001456189us-gaap:RetainedEarningsMember 2026-03-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001456189us-gaap:CommonStockMember 2026-03-31 0001456189us-gaap:PreferredStockMember 2026-03-31 0001456189us-gaap:RetainedEarningsMember 2024-12-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001456189us-gaap:CommonStockMember 2024-12-31 0001456189us-gaap:PreferredStockMember 2024-12-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001456189us-gaap:RetainedEarningsMember 2025-03-31 0001456189us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001456189us-gaap:CommonStockMember 2025-03-31 0001456189us-gaap:PreferredStockMember 2025-03-31 0001456189us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001456189us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001456189us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001456189us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001456189us-gaap:TreasuryStockCommonMember 2025-12-31 0001456189us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001456189us-gaap:TreasuryStockCommonMember 2026-03-31 iso4217:USD iso4217:USDxbrli:shares xbrli:pure xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2026

[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________to _____________

Commission File No. 000-54693

LEATT CORPORATION
(Exact name of registrant as specified in its charter)

Nevada	20-2819367
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

12 Kiepersol Drive, Atlas Gardens, Contermanskloof Road,
Durbanville, Western Cape, South Africa, 7441
(Address of principal executive offices)

+(27) 21-557-7257
(Registrant's telephone number, including area code)

__________________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [_]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X] No [_]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] Emerging growth company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act. [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [_] No [X]

The number of shares outstanding of each of the issuer's classes of common stock, as of May 8, 2026, is as follows:

Class of Securities	Shares Outstanding
Common Stock, $0.001 par value	6,233,056

LEATT CORPORATION

Quarterly Report on Form 10-Q
Three Months Ended March 31, 2026

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION	1

ITEM 1.	FINANCIAL STATEMENTS.	1
ITEM 2.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	14
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	23
ITEM 4.	CONTROLS AND PROCEDURES.	23

PART II	OTHER INFORMATION	24

ITEM 1.	LEGAL PROCEEDINGS.	24
ITEM 1A.	RISK FACTORS.	24
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	24
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	24
ITEM 4.	MINE SAFETY DISCLOSURES.	24
ITEM 5.	OTHER INFORMATION.	24
ITEM 6.	EXHIBITS.	25

- i -

PART I

FINANCIAL INFORMATION

LEATT CORPORATION

CONSOLIDATED BALANCE SHEETS

ASSETS

		March 31, 2026			December 31, 2025
		Unaudited			Audited
Current Assets
Cash and cash equivalents	$	17,014,780		$	12,988,111
Restricted cash		175,996			244,936
Accounts receivable, net		6,262,523			7,904,885
Inventory, net		16,355,242			20,897,693
Payments in advance		1,243,364			1,197,284
Income tax receivable		114,302			734,193
Prepaid expenses and other current assets		4,391,989			3,634,255
Total current assets		45,558,196			47,601,357

Property and equipment, net		3,295,373			3,660,704
Operating lease right-of-use assets, net		262,967			342,413
Deferred tax asset, net		396,294			396,294

Other Assets
Deposits		44,910			45,189

Total Assets	$	49,557,740		$	52,045,957

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable and accrued expenses	$	4,651,604		$	8,595,892
Refund liability		65,084			65,140
Notes payable, current		-			1,804
Operating lease liabilities, current		262,967			309,019
Other current liabilities		32,813			8,370
Short term loan, net of finance charges		540,926			800,000
Total current liabilities		5,553,394			9,780,225

Operating lease liabilities, net of current portion		-			33,394
Total liabilities		5,553,394			9,813,619

Commitments and contingencies

Preferred stock, $.001 par value, 1,120,000 shares authorized, 120,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025		3,000			3,000
Common stock, $.001 par value, 28,000,000 shares authorized, 6,237,561 shares issued and 6,233,773 outstanding as of March 31, 2026 and 6,255,989 shares issued and 6,234,689 outstanding as of December 31, 2025		130,533			130,534
Accumulated other comprehensive loss		(1,097,672	)		(983,640	)
Retained earnings		33,629,797			31,859,103
Additional paid - in capital		11,373,490			11,478,399
Treasury stock, at cost, 3,788 and 21,300 shares of common stock,
as of March 31, 2026 and December 31, 2025, respectively		(34,802	)		(255,058	)
Total stockholders' equity		44,004,346			42,232,338

Total Liabilities and Stockholders' Equity	$	49,557,740		$	52,045,957

The accompanying notes are an integral part of these consolidated financial statements.

LEATT CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

		Three Months Ended
		March 31
		2026			2025
		Unaudited			Unaudited

Revenues	$	19,507,486		$	15,367,864

Cost of Revenues		10,933,059			8,646,851

Gross Profit		8,574,427			6,721,013

Product Royalty Income		372,819			85,298

Operating Expenses
Salaries and wages		2,148,626			1,857,380
Commissions and consulting expenses		235,793			157,722
Professional fees		290,492			360,051
Advertising and marketing		1,061,196			892,057
Office lease and expenses		240,715			169,176
Research and development costs		797,348			664,490
Bad debt expense (recovery)		130,082			(63,504	)
General and administrative expenses		1,210,233			1,012,649
Depreciation		514,616			327,008
Total operating expenses		6,629,101			5,377,029

Income from Operations		2,318,145			1,429,282

Other Income
Interest and other income, net		74,496			82,147
Total other income		74,496			82,147

Income Before Provision for Income Taxes		2,392,641			1,511,429

Provision for Income taxes		621,947			390,305

Net Income Available to Common Shareholders	$	1,770,694		$	1,121,124

Net Income per Common Share
Basic	$	0.28		$	0.18
Diluted	$	0.27		$	0.17

Weighted Average Number of Common Shares Outstanding
Basic		6,236,178			6,217,550
Diluted		6,466,734			6,470,546

Comprehensive Income
Net Income	$	1,770,694		$	1,121,124
Other comprehensive income, net of $0 and $0 deferred income taxes in 2026 and 2025
Foreign currency translation		(114,032	)		66,380

Total Comprehensive Income	$	1,656,662		$	1,187,504

The accompanying notes are an integral part of these consolidated financial statements.

LEATT CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

For the Three Months Ended March 31, 2026

																		Accumulated
	Preferred Stock A			Common Stock								Treasury Stock						Other
	Number of			Number of						Additional		Number of						Comprehensive			Retained		Total
	Shares		Amount	Shares			Amount			Paid - In Capital		Shares			Amount			Loss			Earnings		Equity

Balance, January 1, 2026	120,000	$	3,000	6,234,689		$	130,534		$	11,478,399		21,300		$	(255,058	)	$	(983,640	)	$	31,859,103	$	42,232,338

Restricted stock awards	-		-	6,591			7			184,279		-			-			-			-		184,286

Purchase of treasury stock under share repurchase plan	-		-	(7,507	)		(8	)		8		7,507			(68,940	)		-			-		(68,940	)

Cancellation of treasury stock										(289,196	)	(25,019	)		289,196								-

Net income	-		-	-			-			-		-			-			-			1,770,694		1,770,694

Foreign currency translation adjustment	-		-	-			-			-		-			-			(114,032	)		-		(114,032	)

Balance, March 31, 2026	120,000	$	3,000	6,233,773		$	130,533		$	11,373,490		3,788		$	(34,802	)	$	(1,097,672	)	$	33,629,797	$	44,004,346

The accompanying notes are an integral part of these consolidated financial statements.

LEATT CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

For the Three Months Ended March 31, 2025

										Accumulated
	Preferred Stock A			Common Stock						Other
	Number of			Number of				Additional		Comprehensive			Retained		Total
	Shares		Amount	Shares		Amount		Paid - In Capital		Loss			Earnings		Equity

Balance, January 1, 2025	120,000	$	3,000	6,217,550	$	130,555	$	10,988,316	$	(1,452,335	)	$	28,595,181	$	38,264,717

Restricted stock awards	-		-	-		-		120,837		-			-		120,837

Net income	-		-	-		-		-		-			1,121,124		1,121,124

Foreign currency translation adjustment	-		-	-		-		-		66,380			-		66,380

Balance, March 31, 2025	120,000	$	3,000	6,217,550	$	130,555	$	11,109,153	$	(1,385,955	)	$	29,716,305	$	39,573,058

The accompanying notes are an integral part of these consolidated financial statements.

LEATT CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025

		2026			2025
Cash flows from operating activities
Net income	$	1,770,694		$	1,121,124
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation		514,616			327,008
Stock-based compensation		184,286			120,837
Bad debt expense (recovery)		130,082			(63,504	)
Inventory reserve		37,852			46,291
Gain on sale of property and equipment		(388	)		(14,985	)
Increase in refund liability		(56	)		-
(Increase) decrease in:
Accounts receivable		1,512,281			92,226
Inventory		4,504,599			1,012,261
Payments in advance		(46,080	)		(221,652	)
Prepaid expenses and other current assets		(757,734	)		7,342
Income tax receivable		619,891			409,187
Long-term accounts receivable		-			56,391
Deposits		279			(851	)
Increase (decrease) in:
Accounts payable and accrued expenses		(3,944,289	)		(2,123,551	)
Other current liabilities		24,443			-
Net cash provided by operating activities		4,550,476			768,124

Cash flows from investing activities
Capital expenditures		(166,885	)		(195,826	)
Proceeds from sale of property and equipment		743			15,250
Net cash used in investing activities		(166,142	)		(180,576	)

Cash flows from financing activities
Repayment of notes payable to bank		(1,804	)		(13,003	)
Repayments of short-term loan, net		(259,074	)		(288,465	)
Purchase of treasury stock under share repurchase plan		(68,940	)		-
Net cash used in financing activities		(329,818	)		(301,468	)

Effect of exchange rates on cash, cash equivalents and restricted cash		(96,787	)		45,162

Net increase in cash, cash equivalents and restricted cash		3,957,729			331,242

Cash, cash equivalents and restricted cash - beginning of period		13,233,047			12,368,100

Cash, cash equivalents and restricted cash - end of period	$	17,190,776		$	12,699,342
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents		17,014,780			12,699,342
Restricted cash		175,996			-
Total cash, cash equivalents and restricted cash	$	17,190,776		$	12,699,342
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$	12,180		$	17,170

Other noncash investing and financing activities
Cancellation of treasury shares	$	289,196		$	-

The accompanying notes are an integral part of these consolidated financial statements.

CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1 - Basis of presentation

The consolidated balance sheet as of December 31, 2025, was audited and appears in the Form 10-K filed by the Company with the Securities and Exchange Commission on March 24, 2026. The consolidated balance sheet as of March 31, 2026 and the consolidated statements of operations and comprehensive income for the three months ended March 31, 2026 and 2025, changes in stockholders' equity as of and for the three months ended March 31, 2026 and 2025, cash flows for the three months ended March 31, 2026 and 2025, and the related information contained in these notes have been prepared by management without audit. In the opinion of management, all adjustments (which include only normal recurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles as of March 31, 2026, and for all periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year. Certain information and note disclosures normally included in the Company's annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. While management of the Company believes that the disclosures presented are adequate to make the information not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2025, as filed with the Securities and Exchange Commission in the Company's Form 10-K.

Note 2 - Inventory

Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in first-out (FIFO) method. Inventory consists of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, the Company must make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, the Company utilizes historical experience as well as current market information. The reserve for obsolescence was $548,428 at March 31, 2026 and $510,576 at December 31, 2025.

Note 3 - Operating Leases - Right-of-Use Assets and Lease Liability Obligations

The Company has three non-cancelable operating leases, for office and warehousing space, that expires in January 2027 and February 2027, respectively. Rent expense for these operating leases is recognized over the term of the lease on a straight-line basis.

Below is a summary of the Company's Operating Right-of-Use Assets and Operating Lease Liabilities as of March 31, 2026 and December 31, 2025:

		2026		2025
Assets
Operating lease ROU assets	$	262,967	$	342,413

Liabilities
Operating lease liabilities, current	$	262,967	$	309,019
Operating lease liabilities, net of current portion		-		33,394
Total operating lease liabilities	$	262,967	$	342,413

During the three months ended March 31, 2026 and 2025 the Company recognized operating lease expenses amounting to $78,409 and $71,502, respectively, which are included in office lease and expenses in the Company's consolidated statements of operations and comprehensive income. Generally, the Company's lease agreements do not specify an implicit rate. Therefore, the Company estimates the incremental borrowing rate, which is defined as the interest rate the Company would pay to borrow on a collateralized basis, considering such factors as length of lease term and the risks of the economic environment in which the leased asset operates.

As of March 31, 2026 and December 31, 2025 the following disclosures for the remaining lease terms and incremental borrowing rates were applicable:

Supplemental disclosure	March 31, 2026	December 31, 2025
Weighted average remaining lease term	0.77 years	1.00 years
Weighted average discount rate	3.80%	3.80%

Maturities of lease liabilities as of March 31, 2026 were as follows:

Year ending December 31,		Amounts under Operating Leases
Remaining of 2026		262,683
2027		33,907
Total minimum lease payments	$	296,590
Less: amount representing interest	$	(33,623	)
Total operating lease liabilities	$	262,967

Supplemental cash flow information for the nine months ended March 31, 2026 and 2025 are as follows:

Three months

ended

March 31, 2026

Year ended

December 31, 2025

Cash paid for operating leases

86,997

323,611

Right-of-use assets obtained in exchange for lease obligations

82,317

Note 4 - Prepaid expenses and other current assets

Prepaid expenses and other current assets consist primarily of upfront deposit payments made to contract manufacturers for the manufacturing of the Company's products. Prepaid expenses and other current assets of $4,391,989 and $3,634,255 as of March 31, 2026 and December 31, 2025, respectively, are recorded in current assets on the consolidated balance sheets.

Note 5 - Revolving line of Credit facility

The Company has a $1,500,000 revolving credit facility with a bank, expiring March 1, 2026. Obligations under the line of credit are secured by equipment and fixtures in the United States of America, accounts receivable and inventory of the Company. The interest rate charged transitioned from the Bloomberg Short-Term Bank Yield Index rate to the Secured Overnight Financing Rate ("SOFR") Daily Floating rate plus spread adjustments, as defined. The Company entered into a restated and amended loan agreement effective February 12, 2026, for the revolving line of credit, the restated loan agreement extended the facility with the bank to March 1, 2027, and adjusted the interest rate to the greater of the SOFR Daily Floating rate plus spread adjustment, as defined, or a floor, as defined, plus 2.7%. As of March 31, 2026, and December 31, 2025, there were no advances under the line of credit.

Note 6 - Short-term Loans

The Company carries product liability insurance policies with a U.S. and South African-based insurance carrier. The Company finances payment of both of its product liability insurance premiums over the period of coverage, which is generally twelve months. The U.S. short-term loan is payable through a cash down payment of $$363,945 and in monthly installments of $103,820 over ten months including interest at 8.250%. The South African short-term loan is payable in monthly installments of $6,069 over a ten-month period at a flat interest rate of 3.80%. As of March 31, 2026 and December 31, 2025, $540,926 and $800,000, was outstanding respectively.

Note 7 - Notes payable

Two Eleven entered into a Note Payable with a bank effective December 1, 2022 in the principal amount of $58,075, secured by equipment. The Note is payable in 36 consecutive monthly installments of $1,816, including interest at a fixed rate of 7.8581%, commencing February 5, 2023, and continuing to January 5, 2026. As of March 31, 2026 and December 31, 2025, $0 and $1,804 was outstanding, respectively. The note was paid in full on January 5, 2026

		March 31, 2026		December 31, 2025
Liabilities
Note payable, current	$	-	$	1,804
Note payable, net of current portion	$	-		-
	$	-	$	1,804

Note 8 - Revenue and Cost Recognition

The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers where consumers choose to purchase directly via the Company's e-commerce website (collectively the "customers").

Revenues from product sales are recognized when earned, net of applicable provisions for discounts, consumer direct returns, marketing incentives and allowances in the event of product defect where no exchange of product is possible. Revenues are recognized when performance obligations are satisfied as evidenced by transfer of control of promised goods to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Product royalty income, representing less than 1% of total revenues, is recorded as the underlying product sale occurs, in accordance with the related licensing arrangements.

The Company's standard distributor payment terms range from pre-payment in full to 60 days after shipment and subsequent sales of product by distributors have no effect on the amount and timing of payments due to the Company, however, in limited instances qualified distributors and dealers may be granted extended payment terms during selected order periods. In performing such evaluations, the Company utilizes historical experience, sales performance, and credit risk assessments. Furthermore, products purchased by distributors may not be returned to the Company in the event that any such distributor relationship is terminated.

Since the Company (through its wholly-owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the consumer where the consumer chooses to purchase directly from the Company's ecommerce website and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer and upon shipment of products direct to end consumers which has been sold through digital channels. The Company's standard terms and conditions of sale for non-consumer direct or web based sales do not allow for product returns other than under warranty or exchange arrangements.

International sales (other than in the United States and South Africa) are generally drop-shipped directly from the Company's consolidation warehouse or the third-party manufacturer to the Company's international distributors. Revenue and related cost of revenue are recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned for exchange. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products. Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

In the following table, revenue is disaggregated by the source of revenue:

		Three months ended March 31,
		2026	% of Revenues		2025	% of Revenues
Consumer and athlete direct revenues	$	1,285,518	7%	$	861,186	6%
Dealer direct revenues		4,180,019	21%		3,216,598	21%
International distributor revenues		14,041,949	72%		11,290,080	73%
	$	19,507,486	100%	$	15,367,864	100%

The Company reviews the reserves for customer returns at each reporting period and adjusts them to reflect data available at that time. To estimate reserves for returns, the Company estimates the expected returns and claims based on historical rates as well as events and circumstances that indicate changes to historical rates of product returns and claims. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Refund liabilities are presented within Other current liabilities in the consolidated balance sheet.

Accounts receivable consists of amounts due to the Company from normal business activities. Credit is granted to distributors on an unsecured basis based on credit risk analysis assessments and procedures. The Company continuously monitors both credit reports and collections, communication and payments from customers and maintains an allowance for credit losses based upon the expected credit losses determined utilizing historical experience, the aging of funds outstanding and any specific customer collection issues that have been identified. In determining the amount of the allowance, the Company is required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after the Company has used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within the Company's expectations and the provisions established, macro-economic conditions and customer financial positions are fluid, and the Company cannot guarantee that the Company will continue to experience the same credit loss rates that it has in the past. A significant change in the liquidity or financial position of any of the Company's significant customers could have a material adverse effect on the collectability of the Company's accounts receivable and the future operating results. The allowance for short-term credit losses at March 31, 2026 was $328,292 and at December 31, 2025 was $205,827.

Sales commissions are expensed when incurred, which is generally at the time of sale.

Shipping and handling activities associated with outbound freight, after control over a product has transferred to a customer, are accounted for as a fulfilment cost and are included in revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive income. Revenue recognized from contracts with customers is recorded net of sales taxes, value added taxes, or similar taxes that are collected on behalf of local taxing authorities.

Note 9 - Income Taxes

The Company uses the asset and liability approach to account for income taxes. Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and the income tax basis of assets and liabilities. A valuation allowance is applied against any net deferred tax asset if, based on available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The provision for income taxes included taxes currently payable, if any, plus the net change during the period in deferred tax assets and liabilities recorded by the Company. The Company applies the provisions of FASB ASC Topic 740-10, Accounting for Uncertainty in Income Taxes ("Standard"), which provides that the tax effects from an uncertain tax position can be recognized in the consolidated financial statements only if the position is more likely than not be sustained upon an examination by tax authorities. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, the standard provides guidance on derecognition, classification, interest and penalties; accounting in interim periods, disclosure and transition, and any amounts when incurred would be recorded under these provisions.

The Company's practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of March 31, 2026, the Company has no unrecognized tax benefits.

Note 10 - Net Income Per Share of Common Stock

Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of common stock shares and dilutive potential common shares outstanding during the period. For the three months ended March 31, 2026, the Company had 259,000 potential common shares consisting of 120,000 preferred shares, and options to purchase 139,000 shares outstanding that were potentially dilutive if exercised. For the three months ended March 31, 2025, the Company had 311,000 potential common shares consisting of 120,000 preferred shares, and options to purchase 191,000 shares outstanding that were potentially dilutive if exercised.

Note 11 - Common Stock

Stock-based compensation expense related to vested restricted stock awards during the periods ended March 31, 2026 and 2025 was $184,286 and $120,837 respectively. As of March 31, 2026 and December 31, 2025, there was $1,448,437, and $1,471,530 respectively of unrecognized compensation cost related to unvested restricted stock.

Restricted Stock shall vest and become nonforfeitable in accordance with the vesting schedule contained in the Notice of Restricted Stock Grant, except that 100% of grantee's nonvested shares shall become fully vested upon a change of controls defined in the Notice of Restricted Stock Grant. If grantee's service with the Company ceases for any reason other than grantee's (a) death, (b) disability, (c) retirement, or (d) termination by the Company without cause, any nonvested shares shall be automatically forfeited to the Company.

Share Purchase Plan

On August 12, 2025, the Company announced that the Company's board of directors formally ratified and approved a share purchase plan (the "Plan"). The board of directors has authorized the repurchase of the Company's common stock with a par value of $0.001 per share pursuant to a trading plan that qualifies for the safe harbor provisions of Rule 10b-18 and Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The Plan provides for an aggregate purchase of currently outstanding common stock up to $750,000 commencing August 19, 2025 through December 31, 2025. On December 15, 2025, the Company's board of directors approved the extension of the Plan through March 31, 2026.

Share repurchases may be made from time to time through open market purchases, privately negotiated transactions, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Program does not require the purchase of any minimum number of shares and may be suspended or discontinued at any time.

Payment for shares repurchased under the share purchase plan are funded using the Company's cash on hand and cash flow from operations. As of the effective date, the Company deposited $260,000 with a broker to be held in the Company's name in trust for the purpose of repurchasing the related shares (the "Funded Account"). During the year ended December 31, 2025, the Company replenished the account with $260,000. The Company will replenish the fund as required.

During the periods ending March 31, 2026 and December 31, 2025, 7,507 and 21,300 shares, were repurchased for $68,940 and $255,058, respectively. During the period, 25,019 treasury shares with an aggregate cost of $289,196 were cancelled and retired. All repurchased shares were retired at the end of the Plan period and reflected as a reduction of common stock for the par value of the shares, with the excess applied as a reduction to retained earnings. Restricted Cash as of March 31, 2026 and December 31, 2025 were $175,996 and $244,936, respectively.

Note 12 - Preferred Stock

The Company's preferred stock, when issued, is convertible to common stock at or above the then current market price of the Company's common stock and therefore, contains no beneficial conversion feature. The Preferred Stock is convertible on a 1:1 ratio to common stock. Each holder of the Preferred Stock is not entitled to receive dividends and is entitled to 100 votes for each one share of Preferred Stock.

Note 13 - Recent Accounting Pronouncements

In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic220-40): Disaggregation of Income Statement Expenses. This standard does not change the expense captions presented on the face of the income statement. Instead, it requires the disaggregation of certain expense captions into specified categories within the footnotes to the consolidated financial statements. This accounting standard update is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of this accounting standard update on its consolidated financial statements and related disclosures.

We adopted Accounting Standards Update ("ASU") 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, effective with the quarterly period ending March 31, 2026. We applied the guidance prospectively and elected the practical expedient, which allows entities to assume that current conditions as of the balance sheet date do not change over the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets within the scope of Revenue from Contracts with Customers (Topic 606). The adoption of this guidance did not have a material impact on our consolidated financial statements and disclosures.

The Company evaluated all ASU's issued by the FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on the Company's consolidated financial statements.

Note 14 - Segment Information

The Company manages its operations as a single operating segment for the purpose of assessing performance and making operating decisions, resulting in a single reportable segment. The Company has determined that its Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The Company's CODM reviews the Company's financial information on a consolidated basis for the purpose of making key operating decisions, allocating resources and assessing financial performance.

The key measure of segment profit or loss that the CODM uses to allocate resources and assess performance is the Company's consolidated net income, as reported on the consolidated statements of operations and comprehensive income (loss). In addition, the CODM is regularly provided the significant segment expense categories included in the table below, which are reviewed against budgeted expectations to assist in resource allocation decision-making. The CODM does not review assets in evaluating operating performance, and therefore, such information is not presented.

The following table presents selected financial information with respect to the Company's single operating segment for the three months ended March 31, 2026 and 2025:

		2026		2025

Revenues	$	19,507,486	$	15,367,864
Cost of Revenues		10,933,059		8,646,851
Gross Profit		8,574,427		6,721,013

Product Royalty Income		372,819		85,298

Operating Expenses
Salaries and wages		2,148,626		1,857,380
Professional fees		290,492		360,051
Advertising and marketing		1,061,196		892,057
Research and development		797,348		664,490
General and administrative		1,210,233		1,012,649
Other operating expenses		1,121,206		590,402
Operating Expenses		6,629,101		5,377,029

Income from Operations		2,318,145		1,429,282

Other Income		74,496		82,147
Provision for Income taxes		621,947		390,305

Net Income	$	1,770,694	$	1,121,124

Note 15 - Related Party Transactions

Royalty fees associated with sales of Leatt-Brace® products are paid to Holdings, a company owned by a director, and a related individual who is a preferred shareholder. Royalties are based on 5% of the cash received from net sales of the neck braces worldwide and totaled $39,016 and $25,829 for the periods ended March 31, 2026 and 2025. The term of the royalty agreement is for the life of the intellectual property. As of March 31, 2026 and December 31, 2025, accrued royalties totaled $18,325 and $18,823.

On November 8, 2021, the Company entered into a consulting agreement with Innovation Services Limited, or Innovation, a Jersey limited company in which the Company's founder and chairman is an indirect beneficiary, pursuant to which Innovation served as the Company's exclusive research, development and marketing consultant. Monthly consulting fees amounting to $45,481 were payable effective January 1, 2024 until June 30, 2024, and increased to $47,072 effective July 1, 2024 to June 30, 2025 and increased to $48,437 effective July 1, 2025 until June 30, 2026. During the three-month periods ended March 31, 2026 and 2025, the Company recognized an aggregate of $145,312 and $141,217, respectively in consulting fees to Innovation.

Note 16 - Litigation

From time to time, we may become involved in various lawsuits and legal proceedings in the ordinary course of our business. We are currently not aware of any legal proceedings the ultimate outcome of which, in our judgment based on information currently available, would have a material adverse effect on our business, financial condition or operating results.

On July 31, 2025, a lawsuit was filed against the Company with the Court of the Commissioner of Patents in South Africa, for alleged patent infringement. The litigation is in the initial stage, and no hearing date has yet been set. The Company believes that the lawsuit is without merit and intends to defend itself.

Note 17 - Risks and Uncertainties

The COVID-19 pandemic had an adverse impact on global shipping and supply chains which caused a disruption in our customers' ordering patterns and ultimately inflated certain industry wide stock levels. Although global shipping and supply chain conditions have improved, elevated industry inventory levels in certain markets and product categories may continue to impact levels of dealer and distributor ordering to some extent and ultimately consumer spending in the foreseeable future, which may affect the Company's profitability, and could have a negative impact on the Company's results of operations for the coming periods and beyond.

Changes in U.S. and international trade policies, including the imposition of tariffs and retaliatory measures, have created significant uncertainty in global markets. Our business is exposed to risks associated with these evolving policies, which may materially affect our operations, supply chain, and financial performance. Our products are manufactured in Asia which may be subject to increased tariffs. These tariffs may raise our costs and reduce profit margins if we are unable to pass them on to customers. Tariff changes may lead to delays, shortages, or the need to identify alternative suppliers, which could impact production timelines and product availability. Foreign governments may impose retaliatory tariffs or restrictions, further complicating our international operations and market access. The duration and scope of current and future tariffs remain unpredictable. Legal challenges, Congressional action, or executive orders may alter the landscape abruptly. Uncertainty surrounding trade policy may also delay capital investments, hinder long-term planning, and affect our ability to enter new markets or expand existing ones. If these risks materialize, they could adversely affect our financial condition, results of operations, and stock price.

Note 18 - Subsequent Events

The Company has evaluated all subsequent events through the date the financial statements were released.

During April 2026, the Company cancelled 4,505 shares of the Company's common stock that was repurchased.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Special Note Regarding Forward Looking Statements

This report contains forward-looking statements that are contained principally in the sections entitled "Our Business," "Risk Factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations." These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned "Risk Factors" in this report. In some cases, you can identify forward-looking statements by terms such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "would" and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:

• our expectations regarding growth in the motor sports and bicycle market;

• our expectation regarding increasing demand for protective equipment used in the motor sports and bicycle market;

• our belief that we will be able to effectively compete with our competitors and increase our market share;

• our expectations with respect to increased revenue growth and our ability to achieve profitability resulting from increases in our production volumes; and

• our future business development, results of operations and financial condition.

Also, forward-looking statements represent our estimates and assumptions only as of the date of this quarterly report. You should read this quarterly report and the documents that we reference and filed as exhibits to the quarterly report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

Use of Certain Defined Terms

Except as otherwise indicated by the context, references in this annual report to:

• "Leatt," "we," "us," "our," the "Registrant" or the "Company" are to the combined business of Leatt Corporation, a Nevada corporation, its South African branch, Leatt SA, and its direct, wholly owned subsidiaries, Two Eleven and Leatt Prop;

• "Leatt Prop" refers to Leatt Prop (Pty) Ltd, a South African Company incorporated under the laws of South Africa with registration number: 2022/523867/07;

• "Leatt SA" are to the Company's branch office known as 'Leatt Corporation (Incorporated in the State of Nevada)' incorporated under the laws of South Africa with registration number: 2007/032780/10;

• "Leatt USA" are to Leatt USA, LLC, a Nevada Limited Liability Company;

• "PRC", and "China" are to the People's Republic of China;

• "Two Eleven" refers to Two Eleven Distribution, LLC, a Nevada Limited Liability Company;

• "Securities Act" are to the Securities Act of 1933, as amended, and to "Exchange Act" are to Securities Exchange Act of 1934, as amended;

• "South Africa" are to the Republic of South Africa;

• "U.S. dollar," "$" and "US$" are to the legal currency of the United States;

• "Xceed Holdings" refers to Xceed Holdings CC., a close corporation incorporated under the laws of South Africa, and wholly- owned by The Leatt Family Trust, of which Dr. Christopher J. Leatt, the Company's chairman, is a Trustee and Beneficiary; and

• "ZAR" refers to the South African Rand, the legal currency of South Africa. For all ZAR amounts reported, the dollar amount has been calculated on the basis that $1 = ZAR17.1511 for its March 31, 2026 balance sheet.

Overview of Our Business

We were incorporated in the State of Nevada on March 11, 2005, under the name Treadzone, Inc. We were a shell company with little or no operations until March 1, 2006, when we acquired the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company controlled by the Company's Chairman and founder, Dr. Christopher Leatt. On May 25, 2005, we changed our name to Leatt Corporation in connection with our anticipated acquisition of the Leatt-Brace® rights. Leatt designs, develops, markets and distributes personal protective equipment for participants in all forms of motor sports and leisure activities, including riders of motorcycles, bicycles, snowmobiles and ATVs. The Company sells its products to customers worldwide through a global network of distributors and retailers. Leatt also acts as the original equipment manufacturer for personal protective equipment sold by other international brands.

The Company's flagship products are based on the Leatt-Brace® system, a patented injection molded neck protection system owned by Xceed Holdings, designed to prevent potentially devastating injuries to the cervical spine and neck. The Company has the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Company's Chairman and founder, Dr. Christopher Leatt. The Company also has the right to use apparatus embodying, employing and containing the Leatt-Brace® technology and has designed, developed, marketed and distributed other personal protective equipment using this technology, as well as its own developed technology, including the Company's body protection products, and helmets which it markets under the Leatt® brand.

The Company's research and development efforts are conducted at its research facilities, located at its executive headquarters in Cape Town, South Africa. The Company employs 4 full-time employees who are dedicated exclusively to research, development, and testing. The Company also utilizes consultants, academic institutions and engineering companies as independent contractors or consultants, from time to time, to assist it with its research and development efforts. Leatt products have been tested and reviewed internally and by external bodies. All Leatt products are compliant with applicable European Union directives, or CE certified, where appropriate. Depending on the market, we have other certifications outside of CE. Specifically, all our motorcycle helmets comply with the Economic Commission for Europe (ECE) UN Regulation No. 22 r06, and our bicycle helmet complies with the European Committee for Standardization (CEN) EN-1078 standard. For the US market, our motorcycle helmets comply with the US Department of Transportation (DOT) FMVSS 218 helmet safety standard and our bicycle helmets comply with the US Consumer Product Safety Commission (CPSC) 1203 standard for helmet safety. Our downhill-specific bicycle helmets also comply with the American Society for Testing and Materials (ASTM) F1952 standard for downhill racing safety. For the UK market, substantially all of our motorcycle helmets comply with the Auto Cycle Union (ACU) gold standard, for the Japanese market, our Moto 3.5 helmet with the Japanese Standard Association (JSA) JIS T 8133 standard for protective helmets, and for the Brazilian market our Moto 9.5, Moto 7.5, Moto 3.5, and Moto 2.5 helmets comply with The Brazilian Association of Technical Standards (ABNT) NBR 7471 safety standard. Moto 9.5, Moto 8.5, Moto 7.5, Moto 3.5 and Moto 2.5 ADV 9.5, ADV 8.5 and ADV 7.5 have CCC approval for the market in China. Our Enduro 4.0 helmet, All-Mountain 4.0 helmet and Gravity 5.0 helmet have acquired NTA8776 certification, a new e-bike helmet certification required in the Dutch Technical Agreement (NTA) 8776. The Moto 9.5 has been homologated to FRHPhe-02-2023 for us in FIM sanctioned off-road racing events. We are also working on getting some of our high-end MTB helmets tested at Virginia Polytechnic Institute and State University (V-Tech) in the United States, according to their rating system. In addition to our helmet portfolio, our goggles and sunglasses undergo certification and testing in accordance with applicable international eyewear standards. Within our goggle range, the Velocity 6.5, 5.5 and 4.5 goggles are certified to EN1938 and are impact-tested on the lenses according to MIL-DTL-43511D. The Velocity 6.5 SNX, 5.5 SNX and 4.5 SNX goggles are certified to EN13178 and are also impact-tested to MIL-DTL-43511D. Our MTB 5.0, 4.0 and 4.0 X-Flow goggles are tested to EN1938 and undergo MIL-DTL-43511D lens impact testing. The Vizion 3.5, 2.5 and 2.5s goggles are certified to EN1938, while our MTB 2.0 goggles are tested to EN1938. Within our sunglass range, the SpeedViz Pro and SpeedViz Lite models are tested to EN ISO 12312, ANSI Z87.1 and AS/NZS 1067.1. Our RideViz Pro, RideViz Lite, RideViz Pro S, RideViz Lite S, TheViz Andes, TheViz Sierra, TheViz Pyrenees and MadViz One sunglasses are tested to EN ISO 12312, ANSI Z80.3 and AS/NZS 1067.1.

Our products are predominantly manufactured in China in accordance with our manufacturing specifications, pursuant to outsourced manufacturing arrangements with third-party manufacturers located there, based on agreed terms. We continue to build manufacturing capacity outside China, namely, in Thailand, Cambodia, and Bangladesh. The Company utilizes outside consultants and its own employees to ensure the quality of its products through regular on-site product inspections. Products sold to our international customers are usually shipped directly from our consolidation warehouse or manufacturers' warehouses to customers or their import agents.

Leatt earns revenues through the sale of its products through approximately 61 distributors worldwide and 6 e-commerce partners, who in turn sell its products to retailers. Leatt distributors are required to follow certain standard business terms and guidelines for the sale and distribution of Leatt products. Two Eleven and Leatt SA directly distribute Leatt products to dealers and direct to end consumers through digital channels in the United States and South Africa, respectively.

Principal Factors Affecting Our Financial Performance

We believe that the following factors will continue to affect our financial performance:

• Global Economic Fragility - The ongoing turmoil in the global economy, especially in the U.S., Asia and Europe, may have an impact on our business and our financial condition if economic conditions do not improve. We sell our products through a global network of distributors and dealers who may have difficulty clearing elevated multi-brand stock, previously ordered in response to industry wide supply chain challenges, which in turn could slow new orders and affect our financial performance. If our customers were to experience prolonged slow growth or recession as a result of these conditions or otherwise, we could see a drop-in demand for our products and potentially difficulty in collecting accounts receivables.

• Trade Restrictions - We engage in international manufacturing and sales which exposes us to trade restrictions and disruptions that could harm our business and competitive position. Most of our products are manufactured in China, and the U.S. administration has announced tariffs on certain products imported into the United States with China as the country of origin. While these tariffs have not had a significant impact on the shipment of our products to international markets as at March 31, 2026, we believe that the future imposition of, or significant increases in, the level of tariffs, custom duties, export quotas and other barriers and restrictions by the U.S. on China or other countries could disrupt our supply chain, increase the cost of our raw materials and therefore our pricing, and impose the burdens of compliance with foreign trade laws, any of which could potentially affect our bottom line and sales. While we are in continuous discussions with our manufacturers to ensure there are contingencies in place, we cannot assure you that we will not be adversely affected by changes in the trade laws of foreign jurisdictions where we sell and seek to sell our products.

• Fuel Prices - Significant fluctuations in fuel prices could have both a positive and negative effect on our business and operations. A significant portion of our revenue is derived from international sales and significant fluctuations in world fuel prices could significantly increase the price of shipping or transporting our products which we may not be able to pass on to our customers. On the other hand, fluctuations in fuel prices lead to higher commuter costs which may encourage the increased use of motorcycles and bicycles as alternative modes of transportation and lead to an increase in the market for our protection products.

• Product Liability Litigation - We face an inherent business risk of exposure to product liability claims arising from the claimed failure of our products to help prevent the types of personal injury or death against which they are designed to help protect. Therefore, we have acquired very costly product liability insurance worldwide. We have not experienced any material uninsured losses due to product liability claims, but it is possible that we could experience material losses in the future. After a two-week trial in the United States District Court for the Northern District of Ohio (Eastern) ending on April 17, 2014, a federal jury returned a defense verdict for the Company in the first Leatt-Brace® product liability lawsuit to be tried in the United States. The plaintiffs in that case had alleged that defective product design and failure to warn had caused a motocross rider to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt-Brace®. The Company produced evidence at trial showing that his thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt-Brace®, and that the neck brace likely saved his life (or saved him from quadriplegia) by preventing cervical spine injury. The Company had maintained from the onset that this and a small handful of other lawsuits are without merit and that it would vigorously defend itself in each case. In this case, the plaintiffs subsequently appealed the court's decision, and the parties reached an amicable settlement. Although we carry product liability insurance, a successful claim brought against us could significantly harm our business and financial condition and have an adverse impact on our ability to renew our product liability insurance or secure new coverage.

• Protection of Intellectual Property - We believe that the continued success of our business is dependent on our intellectual property portfolio consisting of globally registered trademarks, design patents and utility patents related to the Leatt-Brace®. We believe that a loss of these rights would harm or cause a material disruption to our business and, our corporate strategy is to aggressively take legal action against any violators of our intellectual property rights, regardless of where they may be. From time to time, we have had to enforce our intellectual property rights through litigation, and we may be required to do so in the future. Such litigation may result in substantial costs and could divert resources and management attention from the operations of our business.

• Fluctuations in Foreign Currencies - We are exposed to foreign exchange risk as our revenues and consolidated results of operations may be affected by fluctuations in foreign currency as we translate these currencies into U.S. dollars when we consolidate our financial results. While our reporting currency is the U.S. Dollar, a portion of our consolidated revenues are denominated in South African Rand, or ZAR, certain of our assets are denominated in ZAR, and our research and marketing operations in South Africa utilize South African labor sources. A decrease in the value of the U.S. dollar in relation to the ZAR could increase our cost of doing business in South Africa. If the ZAR depreciates against the U.S. Dollar, the value of our ZAR revenues, earnings and assets as expressed in our U.S. Dollar financial statements will decline. We have not entered into any hedging transactions in an effort to reduce our exposure to foreign exchange risk. Furthermore, since 76% of our sales are derived outside the U.S., where the U.S. dollar is not the primary currency, significant fluctuations in exchange rates such as the strengthening of the dollar versus our customers' local currency can adversely affect our ability to remain competitive in those areas.

• Natural or Man-made Catastrophic Events - We are exposed to natural or man-made catastrophic events that may disrupt our business and may reduce consumer demand for our products. A disruption or failure of our systems or operations in the event of a natural disaster, health pandemic, such as the outbreak and global spread of COVID-19 or the coronavirus, or a man-made catastrophic event could cause delays in completing sales, continuing production, or performing other critical functions of our business, particularly if a catastrophic event occurred at our primary manufacturing locations or our distributor locations worldwide. Any of these events could severely affect our ability to conduct normal business operations and, as a result, our operating results could be adversely affected. There may also be secondary impacts that are unforeseeable, such as impacts on our consumers and on consumer purchasing behavior, which could cause delays in new orders, delays in completing sales or even order cancellations. The continued mutation and spread of deadly viruses, economic headwinds caused by global quarantines, or the occurrence of any other catastrophic events, could have a negative impact on our sales revenue for the coming periods and beyond.

• Impact of Global Conflict - We are exposed to global conflict, such as the ones in Ukraine and the Middle East, that may disrupt our business and reduce consumer demand for our products. A disruption of global shipping routes, the imposition of government sanctions, or other activities resulting from such conflicts could directly affect consumer demand for our products, cause delays in completing sales, shipping of our products, continuing production or performing other critical functions of our business, particularly if a conflict occurs at our primary manufacturing locations or our distributor locations worldwide. Furthermore, prolonged conflict may have unintended global consequences such as increased inflation and volatility in fuel and transportation costs. While we have conducted due diligence on our customers in Russia to ensure that they do not fall into any sanctioned categories, we have seen a delay in the receipt of receivables in our bank account from the distributors of our products in Russia caused by enhanced screening of Russian funds in compliance with global sanctions against Russia for the war in Ukraine. The prolonging, intensification or expansion of these conflicts into surrounding regions could have an adverse impact on our consumers and on consumer purchasing behavior, and result in delays of new orders and completing sales, order cancellations, or payment and shipping delays. We will continue to monitor these fluid situations and any adverse impact that they may have on the global economy in general and on our business operations and especially that of our customers, and we will develop contingencies as necessary to address any disruptions to our business operations as they arise

Results of Operations

The following summary of our results of operations should be read in conjunction with our financial statements and the notes thereto for the three-month periods ended March 31, 2026 and 2025 included herein.

Comparison of Three Months Ended March 31, 2026 and Three Months Ended March 31, 2025

The following table summarizes the results of our operations during the three-month periods ended March 31, 2026 and 2025 and provides information regarding the dollar and percentage increase or (decrease) in such periods:


		Three months Ended March 31,							Percentage
		2026		2025			Increase		Increase
Item							(Decrease)		(Decrease)

REVENUES	$	19,507,486	$	15,367,864		$	4,139,622		27%
COST OF REVENUES		10,933,059		8,646,851		$	2,286,208		26%
GROSS PROFIT		8,574,427		6,721,013		$	1,853,414		28%
PRODUCT ROYALTY INCOME		372,819		85,298		$	287,521		337%
OPERATING EXPENSES
Salaries and Wages		2,148,626		1,857,380		$	291,246		16%
Commissions and Consulting		235,793		157,722		$	78,071		49%
Professional Fees		290,492		360,051		$	(69,559	)	-19%
Advertising and Marketing		1,061,196		892,057		$	169,139		19%
Office Lease and Expenses		240,715		169,176		$	71,539		42%
Research and Development Costs		797,348		664,490		$	132,858		20%
Bad Debt Expense (Recovery)		130,082		(63,504	)	$	193,586		305%
General and Administrative		1,210,233		1,012,649		$	197,584		20%
Depreciation		514,616		327,008		$	187,608		57%
Total Operating Expenses		6,629,101		5,377,029		$	1,252,072		23%
INCOME FROM OPERATIONS		2,318,145		1,429,282		$	888,863		62%
Other Income		74,496		82,147		$	(7,651	)	-9%
INCOME BEFORE INCOME TAXES		2,392,641		1,511,429		$	881,212		58%
Provision for Income taxes		621,947		390,305		$	231,642		59%
NET INCOME	$	1,770,694	$	1,121,124		$	649,570		58%

Revenues - We earn revenues from the sale of our protective gear comprising of neck braces, body armor, helmets and other products, parts and accessories both in the United States and abroad. Revenues for the three months ended March 31, 2026 were $19.51 million, 27% increase, compared to revenues of $15.37 million for the quarter ended March 31, 2025. This increase in worldwide revenues is primarily attributable to a $1.99 million increase in helmet sales, a $1.72 million increase in body armor sales, a $0.38 million increase in sales of other products, parts and accessories and a $0.05 million increase in neck brace sales. Revenues generated from sales to our customers in the United States were $4.70 million and $3.60 million, for the three months ended March 31, 2026 and 2025, respectively. Revenues associated with international customers were $14.80 million and $11.77, or 76% and 77% of revenues, for the three months ended March 31, 2026 and 2025, respectively. Consumer direct sales and sales to our global distributors continued to increase strongly - increasing by 49% and 24%, respectively, during the first quarter of 2026, as consumer demand for Leatt products and distributor re-ordering continued to improve. Dealer direct sales increased by 30%, as our sales teams and dealer outreach programs, particularly domestically continued to gain momentum.

The following table sets forth our revenues by product line for the three months ended March 31, 2026 and 2025:

		Three months ended March 31,
		2026	% of Revenues		2025	% of Revenues
Neck braces	$	729,048	4%	$	678,295	4%
Body armor		8,590,669	44%		6,870,476	45%
Helmets		5,390,527	28%		3,400,533	22%
Other products, parts and accessories		4,797,242	24%		4,418,560	29%
	$	19,507,486	100%	$	15,367,864	100%

Sales of our flagship neck brace accounted for $0.73 million and $0.68 million, or 4% and 4% of our revenues for the quarters ended March 31, 2026 and 2025, respectively. The 7% increase in neck brace revenues is primarily attributable to a 11% increase in the volume of neck braces sold when compared to the first quarter of 2025.

Our body armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces, knee and elbow guards, off-road motorcycle boots and mountain biking shoes. Body armor sales accounted for $8.59 million and $6.87 million, or 44% and 45% of our revenues for the quarters ended March 31, 2026 and 2025, respectively. The 25% increase in body armor revenues was primarily the result of a 54% increase in the volume of footwear, comprising of motorcycle boots and mountain biking shoes, sold during the 2026 period.

Our helmets accounted for $5.39 million or 28% of our revenues for the three months ended March 31, 2026, as compared to $3.40 million or 22% of our revenues for the same 2025 period. The 59% increase in helmet sales is primarily attributable to a 61% increase in the sales volume of helmets designed for mountain biking and adventure motorcycle riding, when compared to the first quarter of 2025.

Our other products, parts and accessories are comprised of goggles, hydrations bags and apparel items including jerseys, pants, shorts and jackets, sunglasses, bicycle components, as well as aftermarket support items required primarily to replace worn or damaged parts through our global distribution network. Other products, parts and accessory sales accounted for $4.80 million and $4.42 million, or 24% and 29% of our revenues for the quarters ended March 31, 2026 and 2025, respectively. Although sales of our MTB apparel line decreased marginally during the first quarter, the 9% increase in revenues from the sale of other products, parts and accessories is primarily due to a 132% increase in revenues generated from the sale of eyewear comprising sunglasses and goggles during the first quarter of 2026.

Cost of Revenues and Gross Profit - Cost of revenues for the quarters ended March 31, 2026 and 2025 were $10.93 million and $8.65 million, respectively. Gross Profit for the quarters ended March 31, 2026 and 2025 were $8.57 million and $6.72 million, respectively, or 44% and 44% of revenues, respectively. Although geopolitical risk continued to disrupt shipping and logistics in certain regions, management continues to implement supply chain efficiencies and improve the cost of goods sold as a percentage of revenues as far as possible.

Product Royalty Income - Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as on sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the quarters ended March 31, 2026 and 2025 were $372,819 and $85,298, respectively. The 337% increase in product royalty income is due to an increase in the sale of licensed products by licensees during the 2026 period.

Salaries and Wages - Salaries and wages for the quarters ended March 31, 2026 and 2025 were $2.15 million and $1.86 million, respectively. The 16% increase in salaries and wages during the 2026 period was primarily due to the employment of marketing and digital professionals globally as we continue to build a multi-channel sales organization and global consumer facing brand.

Commissions and Consulting Expense - During the quarters ended March 31, 2026 and 2025, commissions and consulting expenses were $235,793 and $157,722, respectively. The 49% increase in commissions and consulting expenses is primarily the result of an increase in commissions paid to sales professionals in the United States during the period in line with an increase in domestic sales when compared to the prior year period.

Professional Fees - Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection and product liability litigation expenses incurred as the Company continues to expand. Professional fees for the quarters ended March 31, 2026 and 2025 were $290,492 and $360,051, respectively. The 19% decrease in professional fees is primarily due to a decrease in audit and corporate legal fees incurred during the 2026 period.

Advertising and Marketing - The Company places paid advertising in various motorsport and bicycle magazines and online media and sponsors a number of events, professional teams and individuals to increase product and brand visibility globally. Advertising and marketing expenses for the quarters ended March 31, 2026 and 2025 were $1,061,196 and $892,057, respectively. The 19% increase in advertising and marketing expenses is the result of costs associated with the production and implementation of coordinated global marketing campaigns that are designed to increase consumer demand for the Companies growing product categories and brand.

Office Lease and Expenses - Office lease and expenses for the quarters ended March 31, 2026 and 2025 were $240,715 and $169,176, respectively. Although, lease expenses relating to our offices and warehouses in the United States and South Africa decreased when compared to the 2025 period, the 42%, increase in office lease and expenses is primarily due to the inclusion of consolidation warehousing costs incurred to facilitate consolidated global shipping during the 2026 period.

Research and Development Costs - These costs consist of the salaries of personnel who are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the quarters ended March 31, 2026 and 2025 were $797,348 and $664,490, respectively. The 20% increase in research and development cost is primarily due to an increase in expenditures on product certification, homologation and product development activities, as the Company continues to refine and build a pipeline of exceptional products.

Bad Debt Expense (Recovery)- Bad debt expense (recovery) for the quarters ended March 31, 2026 and 2025 were $130,082 and ($63,504), respectively. The 305% increase in bad debt expense (recovery) is primarily the result of an increase in the bad debt provision related to an increase in accounts receivable balances in the United States, when compared to the comparative 2025 period.

General and Administrative Expenses - General and administrative expenses consist of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the quarters ended March 31, 2026 and 2025 were $1,210,233 and $1,012,649, respectively. The 20% increase in general and administrative expenses is primarily due to an increase in product liability insurance premiums in line with an increase in sales in North America. Additionally, digital platform development costs increased as the Company continued to optimize and elevate its marketing and sales digital channels.

Depreciation Expense - Depreciation expense for the quarters ended March 31, 2026 and 2025 were $514,616 and $327,008, respectively. The 57% increase in depreciation is primarily due to the accelerated depreciation of long-lived intangible web assets in connection with the impairment and resultant useful life adjustment of these assets.

Total Operating Expenses - Total operating expenses increased by $1.25 million, to $6.63 million in the three months ended March 31, 2026, or 62%, compared to $5.38 million in the 2025 period. This increase is primarily due to the increase in salaries, general and administrative and depreciation expenses that were partially offset by a decrease in professional fees discussed above.

Other Income - Other income for the quarters ended March 31, 2026 and 2025 were $74,496 and $82,147, respectively. The 9% decrease in other income is primarily due to a decrease in interest earned during the first quarter of 2026, when compared to the 2025 first quarter.

Income taxes - Income taxes for the quarters ended March 31, 2026 and 2025 were $621,947 and $390,305, respectively. The increase in income taxes is primarily due to an increase in the provision for income taxes in line with the increase in net income when compared to the prior year period.

Net Income - The net income after income taxes for the quarter ended March 31, 2026 was $1.77 million, as opposed to a net income of $1.12 million for the quarter ended March 31, 2025. This 58% increase in net income is primarily due to the increase in revenues and gross profit that were partially offset by the increase in total operating expenses discussed above.

Liquidity and Capital Resources

At March 31, 2026, we had cash, cash equivalents and restricted cash of $17.19 million. The following table sets forth a summary of our cash flows for the periods indicated:

		March 31,
		2026			2025
Net cash provided by operating activities	$	4,550,476		$	768,124
Net cash used in investing activities	$	(166,142	)	$	(180,576	)
Net cash used in financing activities	$	(329,818	)	$	(301,468	)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	$	(96,787	)	$	45,162
Net increase in cash, cash equivalents and restricted cash	$	3,957,729		$	331,242
Cash, cash equivalents and restricted cash at the beginning of period	$	13,233,047		$	12,368,100
Cash, cash equivalents and restricted cash at the end of period	$	17,190,776		$	12,699,342

Cash, cash equivalents and restricted cash increased by $3,957,729 or 30%, for the three months ended March 31, 2026, when compared to $13,233,047 of cash, cash equivalents and restricted cash on hand at December 31, 2025. The primary sources of cash for the three months ended March 31, 2026 were a decrease in inventory of $4,504,599, net income of $1,770,694, a decrease in income tax receivable of $619,891 and a decrease in accounts receivable of $1,512,281. The primary uses of cash for the three months ended March 31, 2026 were an increase in accounts payable and accrued expenses of $3,944,289 and an increase in prepaid expenses and other current assets of $757,734.

The Company is currently meeting its working capital needs through cash on hand, a revolving line of credit with a bank, as well as internally generated cash from operations. Management believes that its current cash, cash equivalent and restricted cash balances, along with the net cash generated by operations are sufficient to meet its anticipated operating cash requirements for at least the next twelve months. There are currently no plans for any major capital expenditure in the next twelve months. Our long-term financing requirements depend on our growth strategy, which relates primarily to our desire to increase revenue both in the U.S. and abroad.

Obligations under Material Contracts

Pursuant to our Licensing Agreement with Xceed Holdings, a company controlled by Dr. Christopher Leatt, our founder, chairman and head of research and development, we pay Xceed Holdings 4% of all neck brace sales revenue billed and received by the Company on a quarterly basis based on sales of the previous quarter. During the three months ended March 31, 2026 and 2025, the Company paid an aggregate of $31,213 and $20,663, in licensing fees to Xceed Holdings. In addition, pursuant to a separate license agreement between the Company and Mr. J. P. De Villiers, our former director, the Company is obligated to pay a royalty fee of 1% of all our billed and received neck brace sales revenue, in quarterly installments, based on sales of the previous quarter, to a trust that is beneficially owned and controlled by Mr. De Villiers. During the quarters ended March 31, 2026 and 2025, the Company paid and aggregate of $7,803 and $5,166, in licensing fees to Mr. De Villiers.

Dr. Christopher Leatt is compensated in his capacity as our Research and Development consultant, pursuant to our Consulting Agreement, dated November 8, 2021, with Innovation Services Limited, or Innovation, a Jersey limited company in which, Dr. Leatt is an indirect beneficiary. Pursuant to the terms of the agreement, Innovation has agreed to serve as the Company's exclusive research, development and marketing consultant, in exchange for a monthly fee; provided, however, that Dr. Leatt must remain an Innovation director and beneficiary of a majority of its ownership interests during the term of the agreement, and Dr. Leatt must remain the Company's primary point of contact responsible for the oversight, review and delivery of the services to be performed by Innovation under the agreement. The monthly fee payable by the Company to Innovation is $48,437. Innovation may increase its monthly fees, on an annual basis on written notice to the Company, by no greater than the lesser of: (a) five percent (5%) of the prior year's annualized fee; or (b) a percentage equal to then-applicable annual percentage increase in the Consumer Price Index (CPI) published by the United States Department of Labor's bureau of labor statistics, plus one-half percent (0.5%). The parties further agreed that all intellectual property generated in connection with the services provided under the consulting agreement will be the sole property of the Company. The term of the Consulting Agreement will continue unless terminated by either party in accordance with its terms. Either party may terminate the Consulting Agreement upon 6 months' prior written notice, except that the Company may immediately terminate it without notice if the services to be performed by Innovation cease to be performed by Dr. Leatt, if beneficial ownership in Innovation by Dr. Leatt and his immediate family members decreases, or for any other material breach of the agreement. The parties have agreed to settle any dispute under the Consulting Agreement by submission to JAMS for final and binding arbitration pursuant to its Comprehensive Arbitration Rules and Procedures and in accordance with the Expedited Procedures in those Rules. During the three-month periods ended March 31, 2026 and 2025, the Company recognized an aggregate of $145,312 and $141,217, respectively, in consulting fees to Innovation.

In addition to the Consulting Agreement, the Company simultaneously entered into a side letter agreement, dated November 8, 2021, with Dr. Leatt, pursuant to which Dr. Leatt agreed, among other things: (1) not to perform services similar to the services provided under the agreement for any current or future, direct or indirect competitor of the Company or any similar company; (2) not to solicit any current or future employees of the Company for employment with Innovation or any other entity with which he may become affiliated, or to contact or solicit any current or future stockholder or investor of the Company in connection with any matter that is not directly related to the ongoing or future business operations of the Company; and (3) that he will apprise the Company of any business opportunity that he becomes aware of that could benefit the Company so that the Company, can in its sole discretion, make a determination regarding whether to pursue such opportunity in the best interest of the Company and its stockholders. Dr. Leatt further agreed to continue dedicating a majority of his time on matters related to performance of his duties as a director of the Company and to the fulfillment of his obligations to the Company's research and development efforts under the consulting agreement, and the Company will have the right to adjust the amount of the fees payable under the consulting agreement to the extent of any substantial diminution in his fulfillment of such duties and obligations. The foregoing agreements replaced prior agreements in force from June 2018 to November 2021, among the Company, Dr. Leatt and Innovate Services Limited, a Seychelles company, beneficially owned by Dr. Leatt, that wound up operations. The foregoing description of the Consulting Agreement and Side Letter Agreement is qualified in its entirety by reference to the Consulting Agreement and the Side Letter Agreement, copies of which are filed as Exhibits 10.1 and 10.2, respectively, hereto and are incorporated by reference in this report.

The Company is the holder of a $1,500,000 revolving line of credit through March 1, 2026, pursuant to a line of credit agreement with a U.S. bank, dated November 19, 2018, as amended. Advances under the line of credit bear interest at the greater of the Secured Overnight Financing Rate Daily Floating rate plus spread adjustment or an Index Floor of 1.25 percentage points, plus 2.5 percentage points. Effective February 12. 2026, the Company signed Amended and Restated Loan Agreement to extend the revolving line of credit to March 1, 2027, the agreement adjusted the interest rate to the greater of the Secured Overnight Financing Rate Daily Floating rate plus spread SOFR adjustment or the index floor, plus 2.7 percentage points. Obligations under the line of credit are secured by the United States accounts receivable, inventory, and equipment and fixtures of the Company and its subsidiary, Two Eleven Distribution, LLC. As of March 31, 2026 and 2025, respectively there were no advances of the line of credit leaving $1,500,000 and $1,500,000, available for advances.

Critical Accounting Policies

Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period. We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, estimating allowances for doubtful accounts receivable, inventory valuation, impairment of long-lived assets, leases and accounting for income taxes.

Revenue and Cost Recognition - The Company recognizes revenue in accordance with ASC 606 "Revenues from Contracts with Customers". As such the Company has and will continue to review its performance obligations in terms of material customer contractual arrangements in order to verify that revenue is recognized when performance obligations are satisfied on a periodic basis.

All manufacturing of Leatt products is performed by third party subcontractors that are predominately based in China. The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers when there are no dealers or distributors in their geographic area or where consumers choose to purchase directly via the Company's e-commerce website (collectively the "customers").

Revenues from product sales are recognized when earned, net of applicable provisions for discounts and returns and allowances in the event of a product defect where no exchange of product is possible. Revenues are recognized when our performance obligations are satisfied as evidenced by transfer of control of promised goods to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Product royalty income, representing less than 1% of total revenues, is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

Our standard distributor payment terms range from pre-payment in full to sixty (60) days after shipment and subsequent sales of our products by distributors have no effect on the amount and timing of payments due to us, however, in limited instances, qualified distributors and dealers may be granted extended payment terms during selected order periods. In performing such evaluations, the Company utilizes historical experience, sales performance, and credit risk requirements. Furthermore, products purchased by distributors may not be returned to the Company in the event that any such distributor relationship is terminated.

Since the Company (through its wholly-owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the ultimate consumer when there is no dealer in the geographic area or the consumer chooses to purchase directly from the Company's e-commerce website and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer and upon shipment of products direct to end consumers, which have been sold through digital channels. The Company's standard terms and conditions of sale for non-consumer direct sales do not allow for product returns other than under warranty. Web-based direct sales permit products to be returned or exchanged within 30 days of the purchase date.

International sales (other than in the United States and South Africa) are generally drop-shipped directly from our consolidation warehouse or our third-party manufacturing partner to Company's international distributors. Revenue and related cost of revenue is recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned and exchanged due to product quality issues. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products. Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

The Company reviews the reserves for customer returns at each reporting period and adjusts them to reflect data available at that time. To estimate reserves for returns, the Company estimates the expected returns and claims based on historical rates as well as events and circumstances that indicate changes to historical rates of product returns and claims. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Sales commissions are expensed when incurred, which is generally at the time of sale.

Shipping and handling activities associated with outbound freight, after control over a product has transferred to a customer, are accounted for as a fulfilment cost and are included in cost of revenues in the accompanying consolidated statements of operations and comprehensive income (loss). Revenue recognized from contracts with customers is recorded net of sales taxes, value added taxes, or similar taxes that are collected on behalf of local taxing authorities.

Revenue recognized from contracts with customers is recorded net of sales taxes, value added taxes, or similar taxes that are collected on behalf of local taxing authorities.

Allowance for Credit Losses - Accounts receivable consist of amounts due to the Company from normal business activities. Credit is granted to distributors on an unsecured basis based on credit risk analysis procedures. We continuously monitor credit reports, collections, communication and payments from customers and maintain an allowance for credit losses based upon the expected credit losses determined utilizing historical experience and any specific customer collection issues that have been identified. In determining the amount of the allowance, we are required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after we have used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within our expectations and the provisions established, macro-economic conditions and customer financial positions are fluid, and we cannot guarantee that we will continue to experience the same credit loss rates that we have had in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results. The allowance of short-term credit losses at March 31, 2026 and December 31, 2025 was $328,292 and $205,827, respectively.

Inventory Valuation - Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, we make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, we utilize historical experience as well as current market information. The reserve for obsolescence at March 31, 2026 and December 31, 2025 was $548,428 and $510,576, respectively.

Impairment of Long-Lived Assets - The Company reviews its intangible and tangible long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the expected future net cash flows to be generated by the assets. Based on these reviews, the Company recognized an impairment charge of $0 and $234,224 to intangible capitalized website costs as at March 31, 2026 and December 31, 2025, respectively.

Operating Leases - The Company determines if an arrangement is a lease at contract inception. Operating leases are included in the right-of-use assets ("ROU''), and lease liability obligations are included in the Company's consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset of the lease term and lease liability obligations represent its obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. As the Company's leases typically do not provide an implicit rate, the Company estimates its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The ROU asset also includes any lease payments made and excludes lease incentives and lease direct costs. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.

Income Taxes - As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which the temporary differences reverse.

Recent Accounting Pronouncements

See Note 2, "Summary of Significant Accounting Policies" in the Notes to the Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption, or expected adoption and effects on our consolidated financial position, results of operations and cash flows.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to its stockholders.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

As of March 31, 2026, the Company's management, under the direction of its Chief Executive Officer and the Chief Financial Officer, Mr. Sean Macdonald, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in our SEC reports is recorded, processed, summarized and reported within the time periods specified by the SEC's rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, the Company's Chief Executive Officer and Chief Financial Officer determined that the Company's disclosure controls and procedures were deemed to be effective.

Changes in Internal Controls Over Financial Reporting

There were no changes in our internal controls over financial reporting during the period ended March 31, 2026, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

• On July 31, 2025, a lawsuit was filed against the Company with the Court of the Commissioner of Patents in South Africa, for alleged patent infringement. The litigation is in the initial stage, and no hearing date has yet been set. The Company believes that the lawsuit is without merit and intends to defend itself.

ITEM 1A. RISK FACTORS.

There are no material changes from the risk factors previously disclosed in Item 1A "Risk Factors" of our annual report on Form 10-K for the period ended December 31, 2025.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

Except as set forth below, we have no information to disclose that was required to be in a report on Form 8-K during the period covered by this report, but was not reported. There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of this report or incorporated by reference:

Exhibit No.	Description

31.1*	Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*	Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*	Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*	Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101*	Interactive data files pursuant to Rule 405 of Regulation S-T

101.INS	Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document

101.SCH	Inline XBRL Taxonomy Extension Schema Document

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document

104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 12, 2026	LEATT CORPORATION

	By: /s/ Sean Macdonald
	Sean Macdonald
	Chief Executive Officer and Chief Financial Officer
	(Principal Executive, Financial and Accounting Officer)

EXHIBIT INDEX

Exhibit No.	Description

31.1*	Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*	Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*	Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*	Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101*	Interactive data files pursuant to Rule 405 of Regulation S-T

101.INS	Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document

101.SCH	Inline XBRL Taxonomy Extension Schema Document

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document

104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Leatt Corp 10-Q